Quoin Pharmaceuticals, Ltd. Overview
QNRX market data
Business OverviewA provider-written description of this company or fund, with its source and observation date.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.
- Source
- massive
- Observed
- Cadence
- Reference data reviewed periodically
- Status
- fresh
Price HistoryDaily closing prices from recorded market data. The latest point represents the most recent completed daily period; prices can move before the next point appears.
QNRX price chart · 1M
- O
- 4.21
- H
- 4.21
- L
- 4.21
- C
- 4.21
- Vol
- 0.000000
Daily history from Jul 29, 2016
- Source
- US equities market feed
- Observed
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & PerformanceOpen, range, return and notional-volume facts calculated from daily market bars.
- Open
- $4.21
- Previous Close
- $4.21
- Day High
- $4.21
- Day Low
- $4.21
- 52 Week High
- $23.13
- 52 Week Low
- $3.47
- 7 Day Return
- +3.69%
- 30 Day Return
- -7.57%
- 90 Day Return
- -6.24%
- 1 Year Return
- -58.40%
- Daily Notional Volume
- $0 Latest daily bar volume multiplied by its closing price.
Valuation & ProfitabilityProvider-backed valuation, profitability, and range metrics for the selected company. Display-only; never feeds scores or decisions.
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$14.80 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.82 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $3.25 – $23.50 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $18.9M · P/B 0.61.
Company NewsRecent source-attributed headlines linked to this symbol. Repeated headlines and low-signal items are filtered. Open a headline for its source and context.
10 captured
Quoin Pharmaceuticals to Announce Corporate Update and Third Quarter 2026 Financial ResultsFiscal.ai ·
This Robinhood Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For MondayBenzinga ·